JUNS

Conviction 0HealthcareScan · Thu, Jun 25, 2026

JUNS$0.2380-5.93%

ResistanceSupportVol 14

Vol MA14 2.84M

Mar 26Apr 14May 1May 19Jun 8Jun 25

JUPITER NEUROSCIENCES, INC.PHARMACEUTICAL PREPARATIONSwww.jupiterneurosciences.com ↗

Price0.2380

Change-5.93%

Gap-4.62%

Rel volume0.72×

Avg volume3.44M

Avg $ vol870.54K

SMA 200.2443

SMA 500.3092

SMA 2000.8273

Price vs 50-23.02%

Price vs 200-71.23%

MA stackbearish

50/200 cross—

Supertrenddown · 0.3072

RSI (14)44

MACD hist0.01

MACD cross—

Stoch %K / %D36 / 44

ADX (14)35

+DI / −DI26 / 12

RSI divergence—

MACD divergence—

ATR %+12.74%

ADR %9.26%

52w high2.97

52w low0.2050

From 52w high-91.99%

Above 52w low+16.10%

New 52w highNo

SqueezeOn · 6d

Bollinger width27.40%

%B0.41

Donchian pos31.49%

Donchian high0.2900

Donchian low0.2141

AVWAP (52w high)0.3486

vs AVWAP high-31.74%

AVWAP (52w low)0.2820

vs AVWAP low-15.61%

OBV trendUp

Chaikin MF (20)0.04

Today vs 20d0.72×

Avg vol (14d)2.84M

Avg vol (20d)3.44M

Avg $ vol (20d)870.54K

Market cap8.63M

RS 3m (vs SPY)-46.29%

RS 6m (vs SPY)-84.74%

RS line new highNo

Trend template0/8

Technical rank14.5

1 week+3.66%

1 month+3.48%

3 months-32.14%

6 months-78.36%

1 year-78.94%

YTD-76.44%

P/E-1.00

P/B-3.10

P/S396.17

P/FCF—

EPS-0.2500

Div yield—

ROE310.58%

ROA-218.94%

Debt/Eq—

Current0.51

EV/EBITDA—

Gross margin80.59%

Net margin—

Rev growth—

EPS growth-254.35%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value8.63M

Revenue18.65K

Net income-2.06M

Gross profit14.29K

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out36.28M

Employees5

ListedTue, Dec 3, 2024

Free float7.35M

Float %21.4%

Short interest625.77K

Days to cover0.0d

Short volume40.4%

Squeeze score17 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank14.5 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.4744

Support0.1931

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in JUNS

All disclosures →

No recent disclosed trades by Congress in JUNS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in JUNS · 9 buys

Insider	Side	Shares	Value	Traded	Filed
Brady Allison W Director · Stock Option · 2026-06-02	Grant	100K	$0	2026-06-02	2026-06-05
Hemmerly Nicholas H. Director · Stock Option · 2026-06-02	Grant	100K	$0	2026-06-02	2026-06-04
Elmasri Saleem Chief Financial Officer · Stock Option · 2026-06-02	Grant	525.57K	$0	2026-06-02	2026-06-04
Kampf Julie B. Director · Stock Option · 2026-06-02	Grant	100K	$0	2026-06-02	2026-06-04
Silva Alison D. President and COO · Stock Option · 2026-06-02	Grant	1.03M	$0	2026-06-02	2026-06-04
ROSEN CHRISTER CEO and Chairman · Stock Option · 2026-06-02	Grant	747.78K	$0	2026-06-02	2026-06-04
Rosen Alexander Gustaf Erik Chief Administrative Officer · Stock Option · 2026-06-02	Grant	341.84K	$0	2026-06-02	2026-06-04
Weis Holger Director · Stock Option · 2026-06-02	Grant	100K	$0	2026-06-02	2026-06-04
Hayward Marshall A. Chief Scientific Officer · Stock Option · 2026-06-02	Grant	259.23K	$0	2026-06-02	2026-06-04

SEC filings

EDGAR filings in JUNS · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.